GSK taps UK firm for "beyond antibodies" cancer drug technology Fox News GSK taps UK firm for "beyond antibodies" cancer drug technology. Published July 09, 2013. Reuters. Cancer Cells. GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against ... |
